News
Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...
In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results